Chargement en cours...

Novel therapies in thrombotic thrombocytopenic purpura

ESSENTIALS: The standard of care for patients with TTP remains daily plasma exchange in addition to immune suppressive therapy. Despite the improved treatment options for TTP, the acute mortality of TTP remains between 15‐20%. Caplacizumab reduces the time to platelet recovery and the exacerbation r...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Res Pract Thromb Haemost
Auteurs principaux: Masias, Camila, Cataland, Spero R.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2017
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6055500/
https://ncbi.nlm.nih.gov/pubmed/30046703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12066
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!